News Website

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer The Malaysian Reserve

Published: Dec. 5, 2024, 3:36 p.m.

Read Full Article

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - Canada NewsWire

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer Canada NewsWire

Published: Dec. 5, 2024, 2:43 p.m.

Read Full Article

NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer - OncLive

NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer OncLive

Published: Dec. 3, 2024, 5:11 p.m.

Read Full Article

Endometrial Cancer Market Size on Track to Surpass USD 46.86 Billion by 2032 at a 5.8% CAGR | VMR - EIN News

Endometrial Cancer Market Size on Track to Surpass USD 46.86 Billion by 2032 at a 5.8% CAGR | VMR EIN News

Published: Nov. 20, 2024, noon

Read Full Article

Enhancing Endometrial Cancer Diagnosis with AI and MRI - MSN

Enhancing Endometrial Cancer Diagnosis with AI and MRI MSN

Published: Nov. 20, 2024, 11:25 a.m.

Read Full Article

Road to RSNA 2024: MRI Preview - AuntMinnie

Road to RSNA 2024: MRI Preview AuntMinnie

Published: Nov. 14, 2024, 8:23 p.m.

Read Full Article

Enhancing Endometrial Cancer Diagnosis with AI and MRI - AZoRobotics

Enhancing Endometrial Cancer Diagnosis with AI and MRI AZoRobotics

Published: Nov. 12, 2024, 10:57 p.m.

Read Full Article

CXCL5 Expression Linked to Reduced Risk of Endometriosis in MR Analysis - Physician's Weekly

CXCL5 Expression Linked to Reduced Risk of Endometriosis in MR Analysis Physician's Weekly

Published: Nov. 12, 2024, 11:58 a.m.

Read Full Article

MMR Status Doesn’t Impact Outcomes of Chemo in Endometrial Cancer - Cancer Therapy Advisor

MMR Status Doesn’t Impact Outcomes of Chemo in Endometrial Cancer Cancer Therapy Advisor

Published: Oct. 29, 2024, 2:30 p.m.

Read Full Article

Study finds high rates of incidental MRI findings in endometriosis cases - Contemporary Obgyn

Study finds high rates of incidental MRI findings in endometriosis cases Contemporary Obgyn

Published: Oct. 29, 2024, 1:04 p.m.

Read Full Article

Latest Articles

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - Canada NewsWire

NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer - OncLive

Endometrial Cancer Market Size on Track to Surpass USD 46.86 Billion by 2032 at a 5.8% CAGR | VMR - EIN News

Enhancing Endometrial Cancer Diagnosis with AI and MRI - MSN

Road to RSNA 2024: MRI Preview - AuntMinnie

Enhancing Endometrial Cancer Diagnosis with AI and MRI - AZoRobotics

CXCL5 Expression Linked to Reduced Risk of Endometriosis in MR Analysis - Physician's Weekly

MMR Status Doesn’t Impact Outcomes of Chemo in Endometrial Cancer - Cancer Therapy Advisor

Study finds high rates of incidental MRI findings in endometriosis cases - Contemporary Obgyn

Subscribe to Our Newsletter